Lisanti Capital Growth LLC Buys 38,800 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Lisanti Capital Growth LLC increased its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 467.5% during the first quarter, according to its most recent filing with the SEC. The fund owned 47,100 shares of the company's stock after buying an additional 38,800 shares during the quarter. Lisanti Capital Growth LLC owned 0.05% of HealthEquity worth $4,162,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in HQY. Ameritas Investment Partners Inc. grew its stake in shares of HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after acquiring an additional 88 shares during the period. Smartleaf Asset Management LLC increased its stake in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares in the last quarter. State of Michigan Retirement System increased its stake in shares of HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after purchasing an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in shares of HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after purchasing an additional 100 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of HealthEquity by 0.6% during the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock valued at $1,850,000 after buying an additional 106 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of HealthEquity stock traded up $0.75 on Monday, hitting $105.63. 104,719 shares of the company traded hands, compared to its average volume of 852,279. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The company has a market cap of $9.13 billion, a P/E ratio of 77.17, a P/E/G ratio of 1.61 and a beta of 0.49. The firm's 50-day simple moving average is $98.01 and its 200 day simple moving average is $98.02.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The business had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter last year, the business posted $0.80 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the sale, the director now directly owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 304,581 shares of company stock valued at $33,664,018 over the last quarter. 1.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HQY. The Goldman Sachs Group boosted their target price on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. KeyCorp dropped their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Bank of America increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Finally, Royal Bank Of Canada boosted their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $118.09.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.